Medical/Pharmaceuticals
Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London
Industry-leading Centre will provide new collaborative and experiential environment for research, training, and treatments LONDON, May 17, 2021 /PRNewswire/ -- Cynosure announced today the grand opening of its new Cynosure Experience Centre inLondon. Complete with new research and training facil...
2021-05-17 16:00
2078
Nippon Express (China) Becomes First Japanese Company to Acquire GDP Certification in China
TOKYO, May 17, 2021 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NE China"), a local subsidiary of Nippon Express Co., Ltd., has obtained Good Distribution Practice (GDP) certification, effectiveMonday, March 29, 2021, for its Shanghai Pudong Airport CFS, making it the first Jap...
2021-05-17 15:00
4639
Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
SAN FRANCISCO and SUZHOU, China, May 17, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2021-05-17 09:00
5282
ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypertension
PALO ALTO, Calif., May 17, 2021 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices Co., Ltd., today presented the primary endpoint data from the randomized sham-controlled RADIANCE-HTN TRIO ("TRIO") study. In subjects with resistant hypertension, t...
2021-05-17 08:24
1976
Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial
SHANGHAI and HONG KONG, May 17, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and onc...
2021-05-17 08:00
3713
myMedidata Wins 'Best Patient Portal' Award in 2021 MedTech Breakthrough Awards Program
SINGAPORE, May 14, 2021 /PRNewswire/ -- Medidata
2021-05-14 11:00
3499
Antengene Announces the IND Approval for Eltanexor in Patients with Advanced Solid Tumors in Mainland China
SHANGHAI and HONG KONG, May 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-05-14 08:40
5037
WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services
WUXI, China, May 14, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and WuXi STA, a subsidiary of WuXi AppTec, today announced that a joint venture company named WuXi XDC was established to provide end-to-end ...
2021-05-14 08:30
6347
Transcenta Announces Updated Clinical Data from Phase I Study of pH-Dependent PD-L1 Antibody MSB2311 to Be Presented at the 2021 ASCO Annual Meeting
SUZHOU, China, May 14, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced that the updated phase I clinical da...
2021-05-14 08:00
2742
Antengene Announces the Completion of Its Manufacturing Center in Shaoxing to Accelerate the Commercialization of Novel Anti-Cancer Therapies
SHANGHAI and HONG KONG, May 14, 2021 /PRNewswire/ -- Today, Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) successfully hosted an inauguration ceremony for its manufacturing center at the Binhai Life Science and Healthcare Industrial Zone in Shaoxing. The completion of the manufacturi...
2021-05-14 08:00
5310
Improving Cancer Survival Prediction: A New Approach with EpiVax Therapeutics' Ancer Platform
PROVIDENCE, R.I., May 14, 2021 /PRNewswire/ -- EpiVax Therapeutics, Inc. ("EVT") announces the publication"Multi–step screening of neoantigens' HLA and TCR–interfaces improves prediction of survival" inScientific Reports. This study demonstrates a superior method of survival analysis for cancer p...
2021-05-14 00:28
2711
Noise Suppression Technology - Key to Protecting First Responders, Made Possible by Series A Financing Close
CALGARY, AB, May 13, 2021 /CNW/ - Digital noise suppression company, ZeroSound Systems Inc. (ZeroSound), announces the fully subscribed close of its Series A financing with private groupJ.V. Driver Investments Inc. The funds will accelerate international scale and growth and the implementation of...
2021-05-13 22:37
2001
LimaCorporate Announces 1st Surgery Using Physica System Trabecular Titanium™ Tibial Plate
SAN DANIELE DEL FRIULI, Italy, May 13, 2021 /PRNewswire/ -- LimaCorporate ushers in a new age of collaboration and innovation with the 1st surgery with Physica system Trabecular Titanium™ (TT) Tibial Plate. On April 29th, Dr. Ivan De Martino performed his first surgery at Agostino Gemelli IRCCS ...
2021-05-13 20:00
2722
APD presents a series of medical power supplies and lithium-ion UPS at CMEF 2021
TAIPEI, May 13, 2021 /PRNewswire/ -- The CMEF (China International Medical Equipment Fair) is one of the biggest exhibitions of its kind in the world and always shows the latest professional medical equipment available on the global market. The 2021 exhibition will be heldbetween May 13 and 16 at...
2021-05-13 15:27
3042
Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities
BAGSVÆRD, Denmark, May 13, 2021 /PRNewswire/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-we...
2021-05-13 13:00
2046
Ascentage Pharma (6855.HK) Becomes a Constituent of MSCI China Small Cap Index
SUZHOU, China and ROCKVILLE, Md., May 13, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that according to the latest ...
2021-05-13 08:28
2976
Antengene Announces IND Approval in China for a Global Phase III Trial of Selinexor in Advanced or Recurrent Endometrial Cancer
SHANGHAI and HONG KONG, May 13, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-05-13 08:00
3858
Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 in patients with mild COVID-19
Product recently cleared in EU as Class III medical device BALERNA, Switzerland, May 13, 2021 /PRNewswire/ -- APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the ...
2021-05-13 00:48
3380
Discover Six Dynamic Trends to Disrupt the Next Generation of Biopharmaceutical Manufacturing
Technology, industry collaborations and a desire to innovate will help participants sustain their growth momentum and achieve manufacturing scale, finds Frost & Sullivan SANTA CLARA, Calif., May 12, 2021 /PRNewswire/ -- The biopharmaceutical industry is facing its biggest test in recent times. A...
2021-05-12 18:12
1931
Regent Pacific's Unrealised Gain in Venturex Resources Limited Increased to US$10.74 million
Highlights: Unrealised Gain in Venturex Resources Limited * Regent Pacific's investment in Venturex Resources Limited has increased significantly toUS$10.74 million (approximately HK$83.77 million) and a marked to-market value ofUS$13.13 million (approximately HK$102.41million) on its VXR sha...
2021-05-12 15:04
7351
Week's Top Stories
Most Reposted
Agoda Makes it Easier for Travelers to See Relevant Photos in Reviews
[Picked up by 313 media titles]
2026-05-06 12:00
Tonik Becomes the First Standalone Digital Bank in the Philippines to Achieve Profitability
[Picked up by 295 media titles]
2026-05-12 10:15
Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 293 media titles]
2026-05-11 16:20
Avnet and HKSTP Invite Global Startups to New AI Hardware Launchpad
[Picked up by 288 media titles]
2026-05-12 10:00Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
[Picked up by 279 media titles]
2026-05-12 14:00
Most Read
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
2026-05-05 10:01
8269
Amadeus delivers solid Q1 2026 growth, and maintains commercial momentum
2026-05-08 18:30
7656
Massimo Group Launches Sentinel 770 HVAC as Part of Sentinel Product Line Targeting Approximately US$10 Million in 2026 Revenue
2026-05-06 21:20
7077
LightInTheBox to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
2026-05-06 20:00
7071
